CASE DISCUSSION
A Case of Recurrent Pregnancy Loss: Diagnostic and Management Approach
Presented by Dr Saima AsgharViews
1,630,266
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Recurrent pregnancy loss (RPL), defined as two or more consecutive pregnancy losses, affects up to 5% of couples trying to conceive. A thorough diagnostic approach includes evaluation for genetic abnormalities, uterine anomalies, antiphospholipid syndrome, hormonal imbalances, and infections....
Case Summary
- Recurrent pregnancy loss (RPL) is defined as two or more consecutive pregnancy losses before 20 weeks gestation, affecting 1-5% of fertile couples. RPL can be primary, in women who have never had a live birth, or secondary, in women with prior live births. The etiology of RPL is idiopathic in 40-50% of cases, while the remaining 50% can be attributed to genetic, anatomic, endocrine, thrombophilic, immunologic, infectious, lifestyle, and environmental factors.
Speaker Profile
Dr Saima Asghar
Senior Registrar obs & gynae Gurayyat General Hospital Gurayyat KSA, Saudi ArabiaDr. Saima Asghar is a dedicated Senior Registrar in Obstetrics and Gynaecology at Gurayyat General Hospital, Gurayyat, Kingdom of Saudi Arabia. With extensive clinical experience in women\'s health, she specializes in managing high-risk pregnancies, gynecologic emergencies, and minimally invasive procedures. Dr. Asghar is known for her patient-centered approach, combining evidence-based medicine with compassionate care to ensure the well-being of mothers and newborns alike. Her commitment to advancing maternal health continues to make a significant impact in the region’s healthcare landscape.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.